The registry of the International Society for Heart and Lung Transplantation: thirty- first adult lung and heart-lung transplant report 2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33: 1009 24. S3.14.3-4. Bolman RMr, Shumway SJ, Estrin JA, et al. Lung and heart-lung transplantation. Evolution and new applications. Ann Surg. 1991;214:456 68. S3.14.3-5. Atluri P, Gaffey A, Howard J, et al. Combined heart and liver trans- plantation can be safely performed with excellent short- and long- term results. Ann Thorac Surg. 2014;98:858 62. S3.14.3-6. Cannon RM, Hughes MG, Jones CM, et al. A review of the United States experience with combined heart-liver transplantation. Transpl Int. 2012;25:1223 8. S3.14.3-7. Barbara DW, Rehfeldt KH, Heimbach JK, et al. The perioperative management of patients undergoing combined heart-liver trans- plantation. Transplantation. 2015;99:139 44. S3.14.3-8. Simpson KE, Esmaeeli A, Khanna G, et al. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33:170 7. 3.15. Palliative Care S3.15-1. Greutmann M, Tobler D, Colman JM, et al. Facilitators of and bar- riers to advance care planning in adult congenital heart disease. Congenit Heart Dis. 2013;8:281 8. S3.15-2. Tobler D, Greutmann M, Colman JM, et al. Knowledge of and pref- erence for advance care planning by adults with congenital heart disease. Am J Cardiol. 2012;109:1797 800. S3.15-3. Tobler D, Greutmann M, Colman JM, et al. End-of-life in adults with congenital heart disease: a call for early communication. Int J Cardiol. 2012;155:383 7. S3.15-4. Tobler D, Greutmann M, Colman JM, et al. End-of-life care in hospi- talized adults with complex congenital heart disease: care delayed, care denied. Palliat Med. 2012;26:72 9. S3.16-1. Martin L, Khalil H. How much reduced hemoglobin is necessary to generate central cyanosis? Chest. 1990;97:182 5. S3.16-2. 